Search Coverage: Biosimilars

Showing news results and dynamic coverage insights for: Biosimilars

Reading Guide & Coverage Overview

Biosimilars Information Center

Get comprehensive updates, key reports, and detailed insights compiled from verified editorial sources.

Table of Contents

Background to Biosimilars
Core Information
Developments
Video Highlights & Reports
Future Outlook

Background to Biosimilars

Innovator biologics are very specific, highly effective medicines that improve health outcomes in many complex conditions such as ... In the totality-of-the-evidence approach, FDA considers all the available evidence needed to make a regulatory decision about a ... Don't miss our upcoming webinars: today! In this webinar: ○ Discussion on biologics, including an explanation of the ... John Gribben, MD, DSc, FRCPath, FMed Sci from Barts Cancer Institute, London, UK compares the use of generic drugs to ... Dr. Andrew Darkow, PharmD, MBA, BCPS Clinical Assistant Professor at Campbell University College of Pharmacy & Health ... FDA Commissioner Dr. Marty Makary joins 'Squawk Box' to discuss plans to speed up the approval of

The patents on many well-known biological drugs will soon expire, giving drug developers the opportunity to make generic ... The structure of biological products is typically more complex than small molecule drugs. As a result, biologics are often more ... If you were recently diagnosed with a chronic disease, or use infusions or injectables to manage your health, you might be familiar ...